Products/Services Used | Details | Operation |
---|---|---|
Peptide Synthesis> | All constructs are described in Extended data tables 5 and 6. Full length RNF4 variants (genes synthesized by GenScript) were expressed from the pLOU3 vector in Escherichia coli BL21 (DE3) cells, while RNFN 27-118 variants (gene fragments produced as gBlocks by IDT and recombined into pHis-TEV-30a using New England BioLabs HiFi assembly) were expressed from pHis-TEV-30a vector in E. coli Rosetta (DE3) cells as previously described (1,2). 15N-enriched RNF4N 30-118 and 32-133 (gBlocks recombined into pHis-TEV-30a using New England BioLabs HiFi assembly) were expressed from pHis-TEV-30a vector in E. coli Rosetta (DE3) cells as previously described (3). For 15N-enriched peptides cells were grown at 37°C in M9 minimal medium supplemented with 15NH4Cl (Sigma). Samples were purified by Ni-NTA (Qiagen) chromatography following cleavage with TEV protease. RNF4N peptides were further purified to homogeneity by gel filtration (following biotinylation for single-molecule peptides). | Get A Quote |
Post-translational modification of proteins with ubiquitin represents a widely used mechanism for cellular regulation. Ubiquitin is activated by an E1 enzyme, transferred to an E2 conjugating enzyme and covalently linked to substrates by one of an estimated 600 E3 ligases (1). RING E3 ligases play a pivotal role in selecting substrates and priming the ubiquitin loaded E2 (E2~Ub) for catalysis (2,3). RING E3 RNF4 is a SUMO targeted ubiquitin ligase (4) with important roles in arsenic therapy for cancer (4,5) and in DNA damage responses (6,7). RNF4 has a RING domain and a substrate recognition domain containing multiple SUMO Interaction Motifs (SIMs) embedded in a region thought to be intrinsically disordered (8)... More